BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22751117)

  • 41. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto-oncogene.
    Mendes Oliveira D; Grillone K; Mignogna C; De Falco V; Laudanna C; Biamonte F; Locane R; Corcione F; Fabozzi M; Sacco R; Viglietto G; Malanga D; Rizzuto A
    J Exp Clin Cancer Res; 2018 Apr; 37(1):84. PubMed ID: 29665843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability.
    Vargiolu M; Fusco D; Kurelac I; Dirnberger D; Baumeister R; Morra I; Melcarne A; Rimondini R; Romeo G; Bonora E
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2571-8. PubMed ID: 19366855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition.
    Afgar A; Fard-Esfahani P; Mehrtash A; Azadmanesh K; Khodarahmi F; Ghadir M; Teimoori-Toolabi L
    Cancer Biol Ther; 2016 Nov; 17(11):1126-1138. PubMed ID: 27668319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic alterations and expression pattern of CEACAM1 in colorectal adenomas and cancers.
    Song JH; Cao Z; Yoon JH; Nam SW; Kim SY; Lee JY; Park WS
    Pathol Oncol Res; 2011 Mar; 17(1):67-74. PubMed ID: 20524097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
    Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
    Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer.
    Riojas MA; Guo M; Glöckner SC; Machida EO; Baylin SB; Ahuja N
    Cancer Biol Ther; 2007 Nov; 6(11):1710-6. PubMed ID: 17986858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer.
    Park DY; Sakamoto H; Kirley SD; Ogino S; Kawasaki T; Kwon E; Mino-Kenudson M; Lauwers GY; Chung DC; Rueda BR; Zukerberg LR
    Am J Pathol; 2007 Nov; 171(5):1509-19. PubMed ID: 17982127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
    Nesković G; Stanojević B; Palmar I; Dimitrijević B
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRalpha1-expressing cells.
    Lee RH; Wong WL; Chan CH; Chan SY
    J Neurosci Res; 2006 Jan; 83(1):80-90. PubMed ID: 16294336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
    Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
    Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin 24 is induced by the RET/PTC3 oncoprotein and is an autocrine growth factor for epithelial cells.
    Shinohara S; Rothstein JL
    Oncogene; 2004 Sep; 23(45):7571-9. PubMed ID: 15326486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and characterization of RET fusions in advanced colorectal cancer.
    Le Rolle AF; Klempner SJ; Garrett CR; Seery T; Sanford EM; Balasubramanian S; Ross JS; Stephens PJ; Miller VA; Ali SM; Chiu VK
    Oncotarget; 2015 Oct; 6(30):28929-37. PubMed ID: 26078337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho.
    Barone MV; Sepe L; Melillo RM; Mineo A; Santelli G; Monaco C; Castellone MD; Tramontano D; Fusco A; Santoro M
    Oncogene; 2001 Oct; 20(48):6973-82. PubMed ID: 11704822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
    Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
    Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.
    Diaz-Rodriguez E; Garcia-Rendueles AR; Ibáñez-Costa A; Gutierrez-Pascual E; Garcia-Lavandeira M; Leal A; Japon MA; Soto A; Venegas E; Tinahones FJ; Garcia-Arnes JA; Benito P; Angeles Galvez M; Jimenez-Reina L; Bernabeu I; Dieguez C; Luque RM; Castaño JP; Alvarez CV
    Endocrinology; 2014 Nov; 155(11):4329-40. PubMed ID: 25137025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
    Carlomagno F; Melillo RM; Visconti R; Salvatore G; De Vita G; Lupoli G; Yu Y; Jing S; Vecchio G; Fusco A; Santoro M
    Endocrinology; 1998 Aug; 139(8):3613-9. PubMed ID: 9681515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis.
    Mograbi B; Bocciardi R; Bourget I; Juhel T; Farahi-Far D; Romeo G; Ceccherini I; Rossi B
    Mol Cell Biol; 2001 Oct; 21(20):6719-30. PubMed ID: 11564857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ret receptor tyrosine kinase immunoreactivity is altered in glial cell line-derived neurotrophic factor-responsive neurons following lesions of the nigrostriatal and septohippocampal pathways.
    Araujo DM; Hilt DC; Miller PJ; Wen D; Jiao S; Lapchak PA
    Neuroscience; 1997 Sep; 80(1):9-16. PubMed ID: 9252216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor.
    Qi J; Zhu YQ; Luo J; Tao WH
    World J Gastroenterol; 2006 Nov; 12(44):7113-7. PubMed ID: 17131472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.